14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.31 $2.47 Tuesday, 23rd Apr 2024 AKBA stock ended at $1.37. This is 0.735% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 4.44% from a day low at $1.35 to a day high of $1.41.
90 days $1.31 $2.47
52 weeks $0.650 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Oct 25, 2021 $2.91 $2.95 $2.80 $2.86 1 450 338
Oct 22, 2021 $2.90 $2.92 $2.80 $2.91 1 785 732
Oct 21, 2021 $2.90 $3.01 $2.89 $2.90 1 306 283
Oct 20, 2021 $2.89 $2.92 $2.85 $2.87 688 492
Oct 19, 2021 $2.86 $2.89 $2.81 $2.85 1 265 753
Oct 18, 2021 $2.84 $2.87 $2.79 $2.81 1 691 124
Oct 15, 2021 $2.96 $2.96 $2.84 $2.85 1 692 949
Oct 14, 2021 $2.97 $2.99 $2.87 $2.92 1 025 693
Oct 13, 2021 $2.96 $2.98 $2.87 $2.94 1 085 266
Oct 12, 2021 $2.94 $2.97 $2.90 $2.95 1 311 755
Oct 11, 2021 $2.83 $2.97 $2.77 $2.93 1 233 111
Oct 08, 2021 $2.77 $2.85 $2.75 $2.81 1 409 003
Oct 07, 2021 $2.79 $2.85 $2.76 $2.80 1 174 655
Oct 06, 2021 $2.76 $2.84 $2.71 $2.75 1 647 960
Oct 05, 2021 $2.81 $2.90 $2.72 $2.79 2 016 069
Oct 04, 2021 $2.82 $2.89 $2.73 $2.80 2 261 259
Oct 01, 2021 $2.88 $2.88 $2.77 $2.83 1 893 593
Sep 30, 2021 $2.92 $2.96 $2.87 $2.88 1 239 116
Sep 29, 2021 $3.00 $3.00 $2.85 $2.86 1 752 980
Sep 28, 2021 $3.00 $3.03 $2.94 $2.96 1 909 342
Sep 27, 2021 $2.88 $3.10 $2.87 $3.04 2 485 439
Sep 24, 2021 $2.88 $2.94 $2.84 $2.86 1 538 529
Sep 23, 2021 $2.83 $2.91 $2.77 $2.91 1 377 765
Sep 22, 2021 $2.82 $2.89 $2.80 $2.81 974 513
Sep 21, 2021 $2.81 $2.90 $2.80 $2.85 1 182 340
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT